Oppenheimer analyst Leland Gershell reiterated a Perform rating on Alnylam Pharmaceuticals (NASDAQ: ALNY).The analyst commented: "Our look at broader Helios-B ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE